Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

Clinical and Experimental Immunology - Tập 113 Số 3 - Trang 401-406 - 2001
Édouard Louis1,2, Denis Franchimont1, Anthony Piron1, Y. Gevaert2, Nicole Schaaf‐Lafontaine3, Sandrine Roland1, P Mahieu3, Michel Malaise2, Donat De Groote2, Renaud Louis2, Jacques Bélaïche1,2
1Department of Gastroenterology
2Inflammatory Diseases Research Group
3Department of Immunology, CHU of Liège, Liège, Belgium

Tóm tắt

SUMMARYTNF-α is involved in infectious and immuno-inflammatory diseases. Different individuals may have different capacities for TNF-α production. This might determine a predisposition to develop some complications or phenotypes of these diseases. The aims of our study were to assess the inter-individual variability of TNF-α production and to correlate this variability to a single base pair polymorphism located at position −308 in TNF gene. We studied 62 healthy individuals. TNF-α production after LPS stimulation was evaluated using a whole blood cell culture model. The TNF gene polymorphism was studied by an allele-specific polymerase chain reaction. Other cytokines produced in the culture, soluble CD14 concentrations and expression of CD14 on blood cells were also measured. Among the 62 individuals, 57 were successfully genotyped. There were 41 TNF1 homozygotes and 16 TNF1/TNF2 heterozygotes. TNF-α production after LPS stimulation of whole blood cell culture was higher among TNF2 carriers than among TNF1 homozygotes (929 pg/ml (480–1473 pg/ml) versus 521 pg/ml (178–1307 pg/ml); P < 0.05). This difference was even more significant after correction of TNF-α production for CD14 expression on blood cells. In conclusion, the single base pair polymorphism at position −308 in the TNF gene may influence TNF-α production in healthy individuals.

Từ khóa


Tài liệu tham khảo

Beutler B, 1997, Science, 229, 869, 10.1126/science.3895437

Arditi M, 1990, J Infect Dis, 162, 139, 10.1093/infdis/162.1.139

Reinecker HC, 1993, Clin Exp Immunol, 94, 174, 10.1111/j.1365-2249.1993.tb05997.x

10.1016/0140-6736(91)91452-Z

Van Dullemen HM, 1995, Gastroenterology, 109, 129, 10.1016/0016-5085(95)90277-5

10.1016/S0140-6736(94)90628-9

10.1038/330662a0

10.1016/S0140-6736(96)06413-6

Nedospasov SA, 1991, J Immunol, 147, 1053, 10.4049/jimmunol.147.3.1053

10.1084/jem.177.2.557

10.1038/371508a0

Roy S, 1997, J Infect Dis, 176, 530, 10.1086/517282

Conway DJ, 1997, Infect Immun, 65, 1003, 10.1128/IAI.65.3.1003-1006.1997

10.1084/jem.182.5.1259

Louis E, 1996, Gut, 39, 705, 10.1136/gut.39.5.705

10.1073/pnas.94.7.3195

Brinkman BMN, 1996, J Inflam, 46, 32

10.1016/1043-4666(92)90062-V

Entzian P, 1996, Am J Respir Crit Care Med, 153, 1080, 10.1164/ajrccm.153.3.8630548

10.1016/0167-5699(93)90212-4

Schutt C, 1992, Res Immunol, 143, 71, 10.1016/0923-2494(92)80082-V

22 KR Manogue, SJH Van Deventer, and A Cerami . Tumor necrosis factor alpha or cachectin. In: Thomson AW, ed. The cytokine handbook. London: Academic Press, 1991 :241, 56 .

10.1016/0022-1759(93)90130-Y

Verjans GM, 1994, Clin Exp Immunol, 97, 45, 10.1111/j.1365-2249.1994.tb06577.x

10.1016/0198-8859(93)90502-R

Jacob CO, 1990, Proc Natl Acad Sci USA, 87, 1233, 10.1073/pnas.87.3.1233

Pociot F, 1993, Eur J Immunol, 23, 224, 10.1002/eji.1830230135

Plevy SE, 1994, Gastroenterology, 106, A754

Goyert SM, 1986, J Immunol, 137, 3909, 10.4049/jimmunol.137.12.3909

Trinchieri G, 1987, Cancer Res, 47, 2236

Lauener RP, 1990, Eur J Immunol, 20, 2375, 10.1002/eji.1830201103

Passlick B, 1989, Blood, 74, 2527, 10.1182/blood.V74.7.2527.2527

Ziegler-Heitbrock HWL, 1992, Blood, 79, 503, 10.1182/blood.V79.2.503.503

Bazil V, 1991, J Immunol, 147, 1567, 10.4049/jimmunol.147.5.1567

Haziot A, 1994, J Immunol, 152, 5868, 10.4049/jimmunol.152.12.5868

Martin TR, 1992, J Clin Invest, 90, 2209, 10.1172/JCI116106

Tobias PS, 1986, J Exp Med, 164, 777, 10.1084/jem.164.3.777

10.1146/annurev.immunol.13.1.251

10.1084/jem.174.5.1209

Danis VA, 1995, Clin Exp Immunol, 99, 303, 10.1111/j.1365-2249.1995.tb05549.x

Thông tin
Thông tin xuất bản

Clinical and Experimental Immunology

Tập 113 Số 3

401-406

Thông tin tác giả